Only July 8, 2008, the U.S. Food and Drug Administration (FDA) announced that boxed warnings on the labels of fluoroquinolone antimicrobial drugs are necessary. Defective drug lawyers and drug manufacturers are aware that the drugs increase the risk of tendonitis and tendon rupture.

The FDA has also determined that the manufacturers of the drugs are required to supply patients with a Medication Guide to warn them about possible adverse effects.

The FDA has required a Risk Evaluation and Mitigation Strategy be provided by the manufacturers of the antimicrobial drugs. This strategy will help to determine if the benefits of the drugs outweigh the risks.

Fluoroquinolone antimicrobial drugs are prescribed to treat some types of bacterial infections. Defective drug attorneys work to ensure that patients are properly informed about their prescription medications.

This entry was posted on Wednesday, July 9th, 2008 at 1:42 am and is filed under Defective Drugs, Medication, Safety. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.